DK135268B - Process for the preparation of an ophthalmic insulin preparation. - Google Patents

Process for the preparation of an ophthalmic insulin preparation.

Info

Publication number
DK135268B
DK135268B DK69374A DK69374A DK135268B DK 135268 B DK135268 B DK 135268B DK 69374 A DK69374 A DK 69374A DK 69374 A DK69374 A DK 69374A DK 135268 B DK135268 B DK 135268B
Authority
DK
Denmark
Prior art keywords
preparation
ophthalmic
insulin
insulin preparation
ophthalmic insulin
Prior art date
Application number
DK69374A
Other languages
Danish (da)
Other versions
DK135268C (en
Inventor
Tadahide Sato
Hitoshi Ozawa
Minoru Morita
Hirohiko Shimizu
Akiyoshi Nojiri
Etsuko Ozeki
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of DK135268B publication Critical patent/DK135268B/en
Application granted granted Critical
Publication of DK135268C publication Critical patent/DK135268C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK69374A 1973-02-09 1974-02-08 Process for the preparation of an ophthalmic insulin preparation. DK135268B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1570273A JPS5518692B2 (en) 1973-02-09 1973-02-09

Publications (2)

Publication Number Publication Date
DK135268B true DK135268B (en) 1977-03-28
DK135268C DK135268C (en) 1977-09-19

Family

ID=11896086

Family Applications (2)

Application Number Title Priority Date Filing Date
DK135268D DK135268A (en) 1973-02-09
DK69374A DK135268B (en) 1973-02-09 1974-02-08 Process for the preparation of an ophthalmic insulin preparation.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK135268D DK135268A (en) 1973-02-09

Country Status (3)

Country Link
JP (1) JPS5518692B2 (en)
DK (2) DK135268B (en)
GB (1) GB1443662A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987006137A1 (en) * 1986-04-18 1987-10-22 Nordisk Gentofte A/S An insulin preparation for non-parenteral administration
WO2012119007A1 (en) 2011-03-01 2012-09-07 N21 Acquisition Holding, Llc Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders
US10245325B2 (en) 2007-03-13 2019-04-02 Jds Therapeutics, Llc Methods and compositions for the sustained release of chromium
US10363222B2 (en) 2007-06-26 2019-07-30 Jds Therapeutics, Llc Multiple unit dosage form having a therapeutic agent in combination with a nutritional supplement

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4164560A (en) 1977-01-05 1979-08-14 Folkman Moses J Systems for the controlled release of macromolecules
US4391797A (en) 1977-01-05 1983-07-05 The Children's Hospital Medical Center Systems for the controlled release of macromolecules
US4483807A (en) * 1981-01-27 1984-11-20 Japan Atomic Energy Research Institute Process for producing a slow release composite
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
DE3604868A1 (en) * 1986-02-15 1987-08-20 Behringwerke Ag INSULINE DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE
JP2671381B2 (en) * 1988-05-23 1997-10-29 藤沢薬品工業株式会社 Eye drops
US5227372A (en) * 1990-03-07 1993-07-13 Children's Medical Center Corporation Method for retaining ophthalmological agents in ocular tissues
CN109069532A (en) 2016-02-11 2018-12-21 营养21有限责任公司 Composition containing chromium is for improving health and body-building

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987006137A1 (en) * 1986-04-18 1987-10-22 Nordisk Gentofte A/S An insulin preparation for non-parenteral administration
US10245325B2 (en) 2007-03-13 2019-04-02 Jds Therapeutics, Llc Methods and compositions for the sustained release of chromium
US10363222B2 (en) 2007-06-26 2019-07-30 Jds Therapeutics, Llc Multiple unit dosage form having a therapeutic agent in combination with a nutritional supplement
US11241388B2 (en) 2007-06-26 2022-02-08 Jds Therapeutics, Llc Multiple unit dosage form having a therapeutic agent in combination with a nutritional supplement
US11801224B2 (en) 2007-06-26 2023-10-31 Jds Therapeutics, Llc Multiple unit dosage form having a therapeutic agent in combination with a nutritional supplement
WO2012119007A1 (en) 2011-03-01 2012-09-07 N21 Acquisition Holding, Llc Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders
EP4070801A1 (en) 2011-03-01 2022-10-12 Nutrition 21, LLC Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders

Also Published As

Publication number Publication date
GB1443662A (en) 1976-07-21
JPS5518692B2 (en) 1980-05-21
JPS49102827A (en) 1974-09-28
DK135268A (en)
DK135268C (en) 1977-09-19

Similar Documents

Publication Publication Date Title
DK134345B (en) Analogous process for the preparation of 4-hydroxymethyl-1-phthalazone derivatives.
DK135376B (en) Process for the preparation of piperazinylquinazoline compounds.
DK137835B (en) Analogous process for the preparation of thienothiazine derivatives.
DK140484B (en) Process for the preparation of zeaxanthin.
DK134031B (en) Process for the preparation of an endo-beta-glucanase preparation.
DK135268B (en) Process for the preparation of an ophthalmic insulin preparation.
DK139846B (en) Analogous process for the preparation of 3-alkoxypyrazine-2-carboxamides.
DK148282C (en) PROCEDURE FOR THE PREPARATION OF ALKALIMETAL Insulin
DK137389B (en) Analogous process for the preparation of 11beta-substituted delta4-estreners.
DK138759B (en) Process for the preparation of D-ribose.
DK133977B (en) Process for the preparation of 2-chloro-5-sulfamoylbenzoic acids.
DK134279B (en) Analogous process for the preparation of cycloalkylphenoxycarboxylic acid derivatives.
DK137577B (en) Process for the preparation of zeaxanthin.
DK131633B (en) Process for the preparation of 3- (17beta-4-androsten-3-one-17beta-yl) -propiolactone.
DK135723B (en) Analogous process for the preparation of 7alpha-acylthio-3-oxo-D-homo-21,24-dinor-17alpha-chloro-4-ene-23,17a-lactones.
DK137452B (en) Analogous process for the preparation of disubstituted azabicycloalkanes.
DK139716B (en) Analogous process for the preparation of 4-aminoamphetamine derivatives.
DK132328B (en) Analogous process for the preparation of 17beta-hydroxy-16,16-dimethylestr-4-en-3-one.
DK137043B (en) Analogous process for the preparation of nitrocarbostyril compounds.
DK140411B (en) Process for the preparation of deacetoxycephalosporin C.
DK139682B (en) Analogous process for the preparation of eburnamine derivatives.
DK140670B (en) Analogous process for the preparation of ergopeptin derivatives.
DK135943B (en) Process for the preparation of propanolamine derivatives.
DK138694B (en) Process for the preparation of phenylphosphonothiodichloride.
DK137646B (en) Process for the preparation of 6-chloro-2-chloromethyl-4-phenylquinazoline-3-oxide.